Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Ryota Takahashi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7886-8481; OpenAlex author ID A5100724725. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
45
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 9

  1. WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway. Co-author DOI 10.1007/s00535-024-02192-x↗
  2. The Role of Neural Signaling in the Pancreatic Cancer Microenvironment. Co-author DOI 10.3390/cancers14174269↗
  3. Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression. Co-author DOI 10.1136/gutjnl-2019-319912↗
  4. Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer. Co-author DOI 10.1038/s41598-020-78320-3↗
  5. A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Canc… Co-author DOI 10.1158/0008-5472.can-20-0285↗
  6. Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invas… Co-author DOI 10.1038/s41389-018-0117-8↗
  7. β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer. First author DOI 10.1016/j.ccell.2017.11.007↗
  8. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. Co-author DOI 10.18632/oncotarget.11129↗
  9. Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer. Co-author DOI 10.1111/cas.12080↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hideaki Ijichi · 6 shared papers, 2013–2025 · strength 0.74
  2. Mitsuhiro Fujishiro · 2 shared papers, 2022–2025 · strength 0.50
  3. Koji Miyabayashi · 4 shared papers, 2016–2025 · strength 0.45
  4. Keisuke Yamamoto · 3 shared papers, 2016–2025 · strength 0.37
  5. Kenneth P. Olive · 3 shared papers, 2018–2021 · strength 0.26
  6. Timothy Cragin Wang · 3 shared papers, 2018–2021 · strength 0.26
  7. Kazuhiko Koike · 4 shared papers, 2013–2020 · strength 0.24
  8. Takuma Iwata · 1 shared paper, 2025 · strength 0.24
  9. Takahiro Kishikawa · 1 shared paper, 2025 · strength 0.24
  10. Takahiro Seimiya · 1 shared paper, 2025 · strength 0.24
  11. Genso Notoya · 1 shared paper, 2025 · strength 0.24
  12. Motoyuki Otsuka · 1 shared paper, 2025 · strength 0.24
  13. Hiroyuki Isayama · 3 shared papers, 2016–2020 · strength 0.21
  14. Tamas A. Gonda · 2 shared papers, 2020–2021 · strength 0.21
  15. Harold L. Moses · 3 shared papers, 2013–2020 · strength 0.20
  16. Makoto Sano · 2 shared papers, 2019–2020 · strength 0.17
  17. Alina Cornelia Iuga · 2 shared papers, 2018–2021 · strength 0.16
  18. Takayuki Tanaka · 2 shared papers, 2018–2021 · strength 0.16
  19. Marina Macchini · 2 shared papers, 2018–2021 · strength 0.16
  20. Bernhard Willibald Renz · 2 shared papers, 2018–2021 · strength 0.16
  21. Christoph Benedikt Westphalen · 2 shared papers, 2018–2021 · strength 0.16
  22. Yousuke Nakai · 2 shared papers, 2016–2020 · strength 0.13
  23. Ruth Aroon White · 1 shared paper, 2021 · strength 0.11
  24. Masaki Sunagawa · 1 shared paper, 2021 · strength 0.11
  25. Jeanine M. Genkinger · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.